MKI67 and neoplasm: We observed significantly reduced tumor proliferation in both Myr-NE xenografts and its tumor-derived cells compared to Myricetin-treated xenografts, which correlated with the efficient downregulation of Ki67 following Myr-NE treatment (Figures 2A, F).